Cite
Kosaka T, Mizuno R, Shinojima T, et al. The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men ≤ 50 years. Am J Clin Exp Urol. 2014;2(4):332-6
Kosaka, T., Mizuno, R., Shinojima, T., Miyajima, A., Kikuchi, E., Tanaka, N., Shinoda, K., Morita, S., Mikami, S., & Oya, M. (2014). The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men ≤ 50 years. American journal of clinical and experimental urology, 2(4), 332-6.
Kosaka, Takeo, et al. "The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men ≤ 50 years." American journal of clinical and experimental urology vol. 2,4 (2014): 332-6.
Kosaka T, Mizuno R, Shinojima T, Miyajima A, Kikuchi E, Tanaka N, Shinoda K, Morita S, Mikami S, Oya M. The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men ≤ 50 years. Am J Clin Exp Urol. 2014 Dec 25;2(4):332-6. eCollection 2014. PMID: 25606579; PMCID: PMC4297329.
Copy
Download .nbib